Three genes (TNFRSF4, TNFSF14, and KIR3DL1) were selected using LASSO regression analysis from the PAAD cohort based on the abovementioned immune checkpoint-related genes and incorporated into the prognostic gene signature. This evidence concerns the gene TNFRSF4 and pancreatic adenocarcinoma.